ElsevierDrugInformation

Sotrovimab Injection

Learn more about Elsevier’s Drug Patient Education today! Empower and engage your patients to use medication safely.

Jun.26.2023

Sotrovimab Injection

What is this medication?

SOTROVIMAB (SOE troe vi mab) is a monoclonal antibody. It is used to treat COVID-19 in patients who are not hospitalized. It is for patients at risk of getting severe symptoms of COVID-19. It may decrease the risk of developing severe symptoms of COVID-19. It may also decrease the chance of going to the hospital. This medication is no longer approved for use by the FDA.

This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.

How should I use this medication?

This medication is injected into a vein. It is given by your care team in a hospital or clinic setting.

Talk to your care team about the use of this medication in children. While it may be prescribed for children as young as 12 years for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What side effects may I notice from receiving this medication?

Side effects that you should report to your doctor or health care professional as soon as possible:

allergic reactions (skin rash, itching or hives; swelling of the face, lips, or tongue)
fast or slow heartbeat
increase in blood pressure
infusion-related reactions (chest pain or chest tightness, chills, fever, trouble breathing)
low blood pressure (dizziness; feeling faint or lightheaded, falls; unusually weak or tired)
wheezing (trouble breathing with loud or whistling sounds)

Side effects that usually do not require medical attention (report these to your doctor or health care professional if they continue or are bothersome):

diarrhea
pain, redness, or irritation at site where injected

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

any allergies
any serious illness
have received a COVID-19 vaccine
an unusual or allergic reaction to sotrovimab, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
breast-feeding

What may interact with this medication?

COVID-19 vaccines

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What if I miss a dose?

This does not apply. This medicine is not for regular use.

What should I watch for while using this medication?

Your condition will be monitored carefully while you are receiving this medicine. Visit your health care provider for regular checks on your progress. Tell your health care provider if your symptoms do not start to get better or if they get worse.

After receiving this medicine, wait at least 90 days before getting the COVID-19 vaccine. If you have already received your first dose of the COVID-19 vaccine, wait at least 90 days after getting this medicine before getting your second dose of vaccine.